Impact of Optimal Pharmacotherapy on Lipid Profile and Qualitative Features of Atherosclerotic Plaques

NCT05639218 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: Inclisiran

Sponsor

Pauls Stradins Clinical University Hospital